Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide.
暂无分享,去创建一个
Fernando Albericio | Ernest Giralt | Marcelo J Kogan | E. Giralt | F. Albericio | M. S. Fernández | E. Araya | M. Kogan | Simón Guerrero | C. Adura | J. Arias | Eyleen Araya | J. Arias | Simon Guerrero | Jenny L Fiedler | J Ignacio Arias | Carolina Adura | Jose Luis Arias | M Soledad Fernández | J. Fiedler | Eyleen Araya
[1] C. Soto,et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. , 2010, Biochemical and biophysical research communications.
[2] Jack F Douglas,et al. Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.
[3] Neus G Bastús,et al. Peptides conjugated to gold nanoparticles induce macrophage activation. , 2009, Molecular immunology.
[4] Manuela Semmler-Behnke,et al. Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.
[5] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[6] E. Giralt,et al. Gold Nanoparticles and Microwave Irradiation Inhibit Beta-Amyloid Amyloidogenesis , 2008, Nanoscale Research Letters.
[7] Vincent M Rotello,et al. Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.
[8] Leaf Huang,et al. Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.
[9] Parag Aggarwal,et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.
[10] E. Giralt,et al. How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for beta-amyloid fibrils. , 2008, Bioconjugate chemistry.
[11] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[12] Håkan Wallin,et al. Kupffer cells are central in the removal of nanoparticles from the organism , 2007, Particle and Fibre Toxicology.
[13] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[14] Fernando Albericio,et al. Peptides and metallic nanoparticles for biomedical applications. , 2007, Nanomedicine.
[15] J F Hainfeld,et al. Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.
[16] D. Spray,et al. Blood-brain barriers : from ontogeny to artificial interfaces , 2006 .
[17] Vladimir P Zharov,et al. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. , 2006, Biophysical journal.
[18] Younan Xia,et al. Gold Nanocages: Engineering Their Structure for Biomedical Applications , 2005 .
[19] Thomas Kelly,et al. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: Potential for cancer therapy , 2005, Lasers in surgery and medicine.
[20] Miqin Zhang,et al. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[21] Donghoon Lee,et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. , 2005, Nano letters.
[22] H. Ohshima,et al. Colloidal stability of aqueous polymeric dispersions: effect of pH and salt concentration. , 2005, Colloids and surfaces. B, Biointerfaces.
[23] Xiaohua Huang,et al. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.
[24] Hongzhe Sun,et al. Transferrin-mediated gold nanoparticle cellular uptake. , 2005, Bioconjugate chemistry.
[25] Warren C W Chan,et al. Semiconductor quantum dots as contrast agents for whole animal imaging. , 2004, Trends in biotechnology.
[26] Paul R. Lockman,et al. Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability , 2004, Journal of drug targeting.
[27] R. Deane,et al. RAGE (Yin) Versus LRP (Yang) Balance Regulates Alzheimer Amyloid &bgr;-Peptide Clearance Through Transport Across the Blood–Brain Barrier , 2004, Stroke.
[28] Gerhard A Blab,et al. Photothermal heterodyne imaging of individual nonfluorescent nanoclusters and nanocrystals. , 2004, Physical review letters.
[29] J. Kreuter. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. , 2004, Journal of nanoscience and nanotechnology.
[30] Leon Hirsch,et al. Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer , 2004, Technology in cancer research & treatment.
[31] G. Gordillo,et al. Adsorption kinetics of charged thiols on gold nanoparticles , 2004 .
[32] T. Schalkhammer,et al. Resonant nanocluster technology—from optical coding and high quality security features to biochips , 2003 .
[33] R. Stafford,et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] Shu Chien,et al. Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases , 2003 .
[35] Ann Marie Schmidt,et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.
[36] A. Heeger,et al. Beyond superquenching: Hyper-efficient energy transfer from conjugated polymers to gold nanoparticles , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[38] Brahim Lounis,et al. Photothermal Imaging of Nanometer-Sized Metal Particles Among Scatterers , 2002, Science.
[39] Vladimir P Torchilin,et al. Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. , 2002, International journal of pharmaceutics.
[40] Feldmann,et al. Drastic reduction of plasmon damping in gold nanorods. , 2002, Physical review letters.
[41] Vasilis Ntziachristos,et al. High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. , 2002, Bioconjugate chemistry.
[42] D D Allen,et al. Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier , 2002, Drug development and industrial pharmacy.
[43] R M Albrecht,et al. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.
[44] Stella M. Marinakos,et al. Encapsulation, Permeability, and Cellular Uptake Characteristics of Hollow Nanometer-Sized Conductive Polymer Capsules† , 2001 .
[45] P. Couvreur,et al. Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.
[46] K. Wooley,et al. Nanostructured materials designed for cell binding and transduction. , 2001, Biomacromolecules.
[47] A. Zaman. Effect of polyethylene oxide on the viscosity of dispersions of charged silica particles: interplay between rheology, adsorption, and surface charge , 2000 .
[48] J L West,et al. Applications of nanotechnology to biotechnology commentary. , 2000, Current opinion in biotechnology.
[49] J. Kreuter,et al. Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles , 1999, Pharmaceutical Research.
[50] A. McCormick,et al. A closer look at an aggregation model of the Stober process , 1998 .
[51] Hillyer,et al. Correlative Instrumental Neutron Activation Analysis, Light Microscopy, Transmission Electron Microscopy, and X-ray Microanalysis for Qualitative and Quantitative Detection of Colloidal Gold Spheres in Biological Specimens , 1998, Microscopy and Microanalysis.
[52] Claudio Soto,et al. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.
[53] D. A. Kharkevich,et al. Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles , 1997, Pharmaceutical Research.
[54] A. Schinkel,et al. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. , 1996, The Journal of clinical investigation.
[55] R. J. Hunter. Foundations of Colloid Science , 1987 .
[56] E. Verwey,et al. Theory of the stability of lyophobic colloids. , 1955, The Journal of physical and colloid chemistry.
[57] Tae-Jong Yoon,et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[58] Antonio Turiel,et al. Nanoparticle-mediated local and remote manipulation of protein aggregation. , 2006, Nano letters.
[59] V. Venkateswarlu,et al. Novel delivery systems for drug targeting to the brain , 2004 .
[60] J. Yguerabide,et al. Resonance light scattering particles as ultrasensitive labels for detection of analytes in a wide range of applications , 2001, Journal of cellular biochemistry. Supplement.
[61] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.